CID 509302

Schembl7478501

Structural Information

Molecular Formula
C20H26N4O2S
SMILES
CC1(C2CC[C@H](C1C2)CNC3=NN=C(S3)NC(=O)C4=CC=CC=C4OC)C
InChI
InChI=1S/C20H26N4O2S/c1-20(2)13-9-8-12(15(20)10-13)11-21-18-23-24-19(27-18)22-17(25)14-6-4-5-7-16(14)26-3/h4-7,12-13,15H,8-11H2,1-3H3,(H,21,23)(H,22,24,25)/t12-,13?,15?/m0/s1
InChIKey
FEGMIZZSDMPHDI-OPFPJEHXSA-N
Compound name
N-[5-[[(2R)-6,6-dimethyl-2-bicyclo[3.1.1]heptanyl]methylamino]-1,3,4-thiadiazol-2-yl]-2-methoxybenzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

3
Patents

386.17764 Da
Monoisotopic Mass

4.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 387.18492 194.7
[M+Na]+ 409.16686 196.9
[M-H]- 385.17036 195.8
[M+NH4]+ 404.21146 204.6
[M+K]+ 425.14080 196.9
[M+H-H2O]+ 369.17490 181.4
[M+HCOO]- 431.17584 201.9
[M+CH3COO]- 445.19149 201.0
[M+Na-2H]- 407.15231 198.7
[M]+ 386.17709 208.9
[M]- 386.17819 208.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe